EntreMed, Inc. Reports Fourth Quarter and Year-End 2012 Financial Results and Business Outlook For 2013

Published: Mar 21, 2013

ROCKVILLE, Md., March 21, 2013 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported results for the three months and twelve months ended December 31, 2012.

Back to news